Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease
Top Cited Papers
- 25 February 2022
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 240, 1-13
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness
- National Institutes of Health
This publication has 66 references indexed in Scilit:
- Perda auditiva sensorioneural em pacientes com acromegalia em tratamentoBrazilian Journal of Otorhinolaryngology, 2015
- The Role of Growth Factors in Cartilage RepairClinical Orthopaedics and Related Research, 2011
- Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trialBMC Medicine, 2010
- Drug-induced sensorineural deafness caused by antithyroid drugs: a rare side effectJournal of the Royal College of Physicians of Edinburgh, 2010
- A comparative study of age-related hearing loss in wild type and insulin-like growth factor I deficient miceFrontiers in Neuroanatomy, 2010
- Occupational Noise, Smoking, and a High Body Mass Index are Risk Factors for Age-related Hearing Impairment and Moderate Alcohol Consumption is Protective: A European Population-based Multicenter StudyJournal of the Association for Research in Otolaryngology, 2008
- Novel Therapy for Hearing LossOtology & Neurotology, 2007
- Diagnosis and Management of the Patulous Eustachian TubeOtology & Neurotology, 2007
- Large Scale Gene Expression Profiles of Regenerating Inner Ear Sensory EpitheliaPLOS ONE, 2007
- Cochlear Protection by Local Insulin-Like Growth Factor-1 Application Using Biodegradable HydrogelThe Laryngoscope, 2006